Coronary Artery Disease Clinical Trial
— VENTMICS-IIOfficial title:
The Effect of Continued Mechanical Ventilation on the Occurrence of Myocardial Ischemia in Patients Undergoing Totally Endoscopic Coronary Artery Bypass Grafting
The goal of this study is to examine the influence of mechanical ventilation on the occurrence of myocardial ischemia in patients undergoing endo-CABG.
Status | Recruiting |
Enrollment | 180 |
Est. completion date | November 1, 2024 |
Est. primary completion date | September 1, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Patients older than 18 years old - Patients undergoing their first elective endo-CABG procedure using peripheral cannulation for CPB - Patients who are able to give their informed consent - Patients who speak Dutch or French Exclusion Criteria: - Patients participating in another clinical trial - Patients taking corticosteroids - Patients with an ejection fraction < 25% - Patients with lung diseases (chronic obstructive pulmonary disease (COPD), asthma) - Patients where groin cannulation is not possible |
Country | Name | City | State |
---|---|---|---|
Belgium | Jessa Hospital | Hasselt |
Lead Sponsor | Collaborator |
---|---|
Jessa Hospital |
Belgium,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The influence of continued mechanical ventilation on the release of cardiac troponin T (cTn-T) | Cardiac troponin T is represented in ng/L. If the value of cTn-T exceeds 14 ng/L, then cTn-T is able to detect myocardial ischemia at the predefined time points. | Until 24 hours after clamping the aorta | |
Primary | The influence of continued mechanical ventilation on the release of creatine kinase-myocardial band (CK-MB) | Creatine kinase-myocardial (CK-MB) band is represented in µg/L. If the value of CK-MB exceeds 6.2 µg/L, then CK-MB is able to detect myocardial ischemia at the predefined time points. | Until 24 hours after clamping the aorta | |
Primary | The influence of continued mechanical ventilation on the release of heart-type fatty acid-binding protein (hFABP) | Heart-type fatty acid-binding protein (hFABP) is represented in ng/L. If the value of hFABP exceeds 6 ng/L, then hFABP is able to detect myocardial ischemia at the predefined time points. | Until 5 hours after clamping the aorta | |
Primary | The influence of continued mechanical ventilation on lipid peroxidation | Lipid peroxidation is measured using the malondialdehyde assay. | Until unclamping the aorta (on average until 64 minutes after clamping the aorta) | |
Primary | The influence of continued mechanical ventilation on the redox balance | superoxide dismutase 1 and 2 (SOD1, SOD2), nuclear factor erythroid 2-related factor 2 (Nrf2), catalase (CAT), glutathione peroxidase (GPx), NADPH oxidase 2 and 4 (NOX2, NOX4), heme oxygenase-1 (HO-1), NAD(P)H quinone oxidoreductase 1 (NQO-1)) will be studied to determine the redox balance. | Until unclamping the aorta (on average until 64 minutes after clamping the aorta) ] | |
Primary | The influence of continued mechanical ventilation on the partial pressure of oxygen (pO2) | pO2 is represented in mmHg. If pO2 is lower than 60 mmHg, then hypoxemia is present. | Until the end of surgery (on average until 203 minutes after the start of the surgery) | |
Primary | The influence of continued mechanical ventilation on the partial pressure of carbon dioxide (pCO2) | pCO2 is represented in mmHg. | Until the end of surgery (on average until 203 minutes after the start of the surgery) | |
Primary | The influence of continued mechanical ventilation on the pH | The pH will measure the acidity. | Until the end of surgery (on average until 203 minutes after the start of the surgery) | |
Primary | The influence of continued mechanical ventilation on lactate | Lactate is represented in mmol/L. | Until the end of surgery (on average until 203 minutes after the start of the surgery) | |
Secondary | The occurence of myocardial infarction | This is based on the Fourth universal definition of myocardial infarction (2018). | Until 30 days after surgery | |
Secondary | The occurence of mortality | All-cause mortality is evaluated. | Until 30 days after surgery | |
Secondary | The occurence of neurological complications | Neurological complications include cerebrovascular accident (CVA), transient ischemic attack (TIA), delirium, epilepsy | Until 30 days after surgery | |
Secondary | The occurence of graft failure | Graft failure describes total graft occlusion that prevents blood flow through the graft to the revascularized part of the heart. | Until 30 days after surgery |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06030596 -
SPECT Myocardial Blood Flow Quantification for Diagnosis of Ischemic Heart Disease Determined by Fraction Flow Reserve
|
||
Completed |
NCT04080700 -
Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA)
|
||
Recruiting |
NCT03810599 -
Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study
|
N/A | |
Recruiting |
NCT06002932 -
Comparison of PROVISIONal 1-stent Strategy With DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions.
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT05308719 -
Nasal Oxygen Therapy After Cardiac Surgery
|
N/A | |
Recruiting |
NCT04242134 -
Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions
|
N/A | |
Completed |
NCT04556994 -
Phase 1 Cardiac Rehabilitation With and Without Lower Limb Paddling Effects in Post CABG Patients.
|
N/A | |
Recruiting |
NCT05846893 -
Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease
|
N/A | |
Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
Recruiting |
NCT05023629 -
STunning After Balloon Occlusion
|
N/A | |
Completed |
NCT04941560 -
Assessing the Association Between Multi-dimension Facial Characteristics and Coronary Artery Diseases
|
||
Completed |
NCT04006288 -
Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease
|
Phase 4 | |
Completed |
NCT01860274 -
Meshed Vein Graft Patency Trial - VEST
|
N/A | |
Recruiting |
NCT06174090 -
The Effect of Video Education on Pain, Anxiety and Knowledge Levels of Coronary Bypass Graft Surgery Patients
|
N/A | |
Completed |
NCT03968809 -
Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes
|
||
Terminated |
NCT03959072 -
Cardiac Cath Lab Staff Radiation Exposure
|
||
Recruiting |
NCT05065073 -
Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography
|
Phase 4 | |
Recruiting |
NCT04566497 -
Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up.
|
N/A | |
Completed |
NCT05096442 -
Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions
|
N/A |